This was within the range reported by previous real-world studies: 2639% and 1672% of incident users received the 0.5 mg and 1.0 mg formulations, respectively, while 13% to 30% and 6788% of prevalent users received the 0.5 mg and 1.0 mg formulations, respectively [13, 20,21,22]
Its clinical program spans over 25,000 participants across the SUSTAIN, PIONEER, STEP, and SELECT trial programs
What Is Jaundice and What Causes It
This treatment works by mimicking GLP-1, a natural hormone that regulates appetite and blood sugar levels
PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p